These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

379 related items for PubMed ID: 8015547

  • 21. Constitutive transactivation by the thyroid hormone receptor and a novel pattern of activity of its oncogenic homolog v-ErbA in Xenopus oocytes.
    Nagl SB, Nelson CC, Romaniuk PJ, Allison LA.
    Mol Endocrinol; 1995 Nov; 9(11):1522-32. PubMed ID: 8584030
    [Abstract] [Full Text] [Related]

  • 22. Understanding the molecular mechanism of dominant negative action of mutant thyroid hormone beta 1-receptors: the important role of the wild-type/mutant receptor heterodimer.
    Zhu XG, Yu CL, McPhie P, Wong R, Cheng SY.
    Endocrinology; 1996 Feb; 137(2):712-21. PubMed ID: 8593822
    [Abstract] [Full Text] [Related]

  • 23. The specificity of interactions between nuclear hormone receptors and corepressors is mediated by distinct amino acid sequences within the interacting domains.
    Cohen RN, Brzostek S, Kim B, Chorev M, Wondisford FE, Hollenberg AN.
    Mol Endocrinol; 2001 Jul; 15(7):1049-61. PubMed ID: 11435607
    [Abstract] [Full Text] [Related]

  • 24. The unique C-termini of the thyroid hormone receptor variant, c-erbA alpha 2, and thyroid hormone receptor alpha 1 mediate different DNA-binding and heterodimerization properties.
    Katz D, Berrodin TJ, Lazar MA.
    Mol Endocrinol; 1992 May; 6(5):805-14. PubMed ID: 1318505
    [Abstract] [Full Text] [Related]

  • 25. General receptor for phosphoinositides 1, a novel repressor of thyroid hormone receptor action that prevents deoxyribonucleic acid binding.
    Poirier MB, Hamann G, Domingue ME, Roy M, Bardati T, Langlois MF.
    Mol Endocrinol; 2005 Aug; 19(8):1991-2005. PubMed ID: 15878955
    [Abstract] [Full Text] [Related]

  • 26. Thyroid hormone receptor mutations that interfere with transcriptional activation also interfere with receptor interaction with a nuclear protein.
    O'Donnell AL, Rosen ED, Darling DS, Koenig RJ.
    Mol Endocrinol; 1991 Jan; 5(1):94-9. PubMed ID: 1850112
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Basal and thyroid hormone receptor auxiliary protein-enhanced binding of thyroid hormone receptor isoforms to native thyroid hormone response elements.
    Yen PM, Darling DS, Chin WW.
    Endocrinology; 1991 Dec; 129(6):3331-6. PubMed ID: 1954909
    [Abstract] [Full Text] [Related]

  • 33. A domain containing leucine-zipper-like motifs mediate novel in vivo interactions between the thyroid hormone and retinoic acid receptors.
    Forman BM, Yang CR, Au M, Casanova J, Ghysdael J, Samuels HH.
    Mol Endocrinol; 1989 Oct; 3(10):1610-26. PubMed ID: 2558297
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Amino acid substitutions of thyroid hormone receptor-beta at codon 435 with resistance to thyroid hormone selectively alter homodimer formation.
    Nomura Y, Nagaya T, Tsukaguchi H, Takamatsu J, Seo H.
    Endocrinology; 1996 Oct; 137(10):4082-6. PubMed ID: 8828460
    [Abstract] [Full Text] [Related]

  • 37. RZRs, a new family of retinoid-related orphan receptors that function as both monomers and homodimers.
    Carlberg C, Hooft van Huijsduijnen R, Staple JK, DeLamarter JF, Becker-André M.
    Mol Endocrinol; 1994 Jun; 8(6):757-70. PubMed ID: 7935491
    [Abstract] [Full Text] [Related]

  • 38. Retinoid X receptor-alpha and apolipoprotein AI regulatory protein 1 differentially modulate 3,5,3'-triiodothyronine-induced transcription.
    Rhee M, Ikeda M, Chin WW.
    Endocrinology; 1995 Jun; 136(6):2697-704. PubMed ID: 7750494
    [Abstract] [Full Text] [Related]

  • 39. Augmentation of thyroid hormone receptor-mediated transcription by Ca2+/calmodulin-dependent protein kinase type IV.
    Kuno-Murata M, Koibuchi N, Fukuda H, Murata M, Chin WW.
    Endocrinology; 2000 Jun; 141(6):2275-8. PubMed ID: 10830318
    [Abstract] [Full Text] [Related]

  • 40. The lack of transcriptional activation of the v-erbA oncogene is in part due to a mutation present in the DNA binding domain of the protein.
    de Verneuil H, Metzger D.
    Nucleic Acids Res; 1990 Aug 11; 18(15):4489-97. PubMed ID: 1975094
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.